Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 171,141 shares at $99.25 ($17.0M) on 2018-06-13, disclosed to the SEC on 2018-06-15.
Open-market sale of $17.0M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.25 | 63,963 | $6.3M | 37.3% |
| 2 | $99.25 | 63,963 | $6.3M | 37.3% |
| 3 | $100.11 | 20,215 | $2.0M | 11.9% |
| 4 | $100.11 | 20,215 | $2.0M | 11.9% |
| 5 | $100.00 | 2,785 | $279K | 1.6% |
| Total | $99.47 avg | 171,141 |
| $17.0M |
| 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |